Mobile health company AirStrip Technologies filed a lawsuit this week against mVisum over recently issued patents for remote patient data monitoring on iPhones, iPads and other smartphones.
AirStrip in late August won the patents in question, which detail the process of “mobilizing” physiologic data for smartphones, tablets and other mobile devices.
Rival mVisum also develops mobile solutions for receiving, viewing and responding to patient data, including EKGs, alarms and MRIs, among others.
San Antonio-based AirStrip has FDA clearance for its remote patent monitoring solution, which it won in July 2010. The system gained CE Mark approval in the European Union in January 2012. The suite of applications allow physicians real-time access to patient vital signs and other clinical information.
mVisum also has U.S. regulatory clearance to market its mobile monitoring technology, including its Alert Alarm Management System.
AirStrip called its mobile monitoring patents "key to more quickly evolving mobility as the foundation for clinical transformation."
“AirStrip has a responsibility to exercise its patent protection in ways that rapidly drive the evolution of mHealth in a uniform and positive direction,” AirStrip CEO Alan Portela said in prepared remarks. “AirStrip respects the intellectual property of others, and will vigorously defend our own. Such action is not taken lightly, but we feel it is in the best interest of providers, our partners, and ultimately, patients.”
On June 4-5, DeviceTalks Minnesota is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring.
Join leaders from 3M, Abbott, Bigfoot Biomedical, Boston Scientific, Cardionomic, CMF Solutions, Cyient, Google Mayo Clinic, Medical Alley, Medtronic, NxThera, Opus College, Relievant Medsystems, University of Minnesota, Star Tribune, Smith & Nephew, Spry Health, Zimmer Biomet and many more when you register today.
Use the code "DTWeb" to save 15% on the cost of registration.